Study on cancer risk assessment method using 5-aminolevulinic acid
- Conditions
- ung cancer, colon cancer, stomach cancer, breast cancer
- Registration Number
- JPRN-UMIN000039304
- Lead Sponsor
- Teikyo University School of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Not provided
1) Patients with a history or diagnosis of porphyria 2) Pregnant women or patients who may become pregnant or breastfeeding 3) Patients who have difficulty in filling in the consent form or have problems with the urine collection procedure due to psychiatric complications, etc. 4) Patients with primary tumors other than the target 4 carcinomas 5) Patients who underwent high-concentration vitamin C therapy or treatment with 5-ALA, such as heat, radiation, or other phototherapy, one month before urine collection 6) Patients with severe cardiovascular disease, lung, liver, or kidney disease who are undergoing treatment or are at risk for it 7) Patients who are required to prescribe drugs separately prescribed on the day of urine collection 8) Other patients who are judged inappropriate by the doctor's judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method